RPI's Rights to Ribozyme Products. Subject to the following Sections 4.2.1 and 4.2.2, RPI shall exclusively and diligently perform its obligations for the development of Ribozymes in the Field with LILLY.
Appears in 3 contracts
Samples: License Agreement (Ribozyme Pharmaceuticals Inc), License Agreement (Ribozyme Pharmaceuticals Inc), Collaboration and License Agreement (Ribozyme Pharmaceuticals Inc)
RPI's Rights to Ribozyme Products. Subject to the following Sections 4.2.1 and 4.2.2, RPI shall exclusively and diligently perform its obligations for the development of Ribozymes in the Field with LILLY.. 4.2.1 DUE DILIGENCE FAILURE. [ * ] 4.2.2 TERMINATION OF A RIBOZYME PRODUCT. [ * ] [*] Confidential treatment requested
Appears in 1 contract
Samples: Research Collaboration and License Agreement (Ribozyme Pharmaceuticals Inc)
